Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,219,253
-
Share change
-
-2,521,188
-
Total reported value
-
$42,524,000
-
Put/Call ratio
-
187%
-
Price per share
-
$3.48
-
Number of holders
-
67
-
Value change
-
-$7,604,966
-
Number of buys
-
31
-
Number of sells
-
27
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q1 2019
As of 31 Mar 2019,
ACELRX PHARMACEUTICALS INC - COM (ACRX) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,219,253 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Laurion Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BRIDGEWAY CAPITAL MANAGEMENT INC, GOLDMAN SACHS GROUP INC, D. E. Shaw & Co., Inc., and MOORE CAPITAL MANAGEMENT, LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.